Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Froehner

Showing results (21-30 of 191) with videos related to

Pageof 20
Sort By:
The Journal of Urology|May 20, 2015
Should the Urologist Treat Castration Resistant Prostate Cancer? YesManfred P Wirth, Michael Froehner
European Urology|July 4, 2012
Words of wisdom. Re: Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trialsMichael Froehner, Manfred P Wirth
European Urology|December 4, 2012
Re: Vincenzo Ficarra, Giacomo Novara, Raymond C. Rosen, et al. systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol 2012;62:405-17Michael Froehner, Manfred P Wirth
European Urology|January 29, 2010
Robot-assisted radical prostatectomy: the new gold standard?Manfred P Wirth, Michael Froehner
European Urology|October 6, 2014
Re: Firas Abdollah, Giorgio Gandaglia, Nazareno Suardi, et al. More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer. Eur Urol 2015;67:212-9: Extended Lymph Node Dissection and the Will Rogers PhenomenonMichael Froehner, Manfred P Wirth
The New England Journal of Medicine|October 30, 2014
Enzalutamide in metastatic prostate cancer before chemotherapyMichael Froehner, Manfred P Wirth
Lancet (London, England)|January 11, 2011
Cabazitaxel for castration-resistant prostate cancerMichael Froehner, Manfred P Wirth
Journal of Comparative Effectiveness Research|October 29, 2014
Approaches to radical prostatectomyMichael Froehner, Manfred P Wirth
Drugs & Aging|October 8, 2013
Locally advanced prostate cancer: optimal therapy in older patientsMichael Froehner, Manfred P Wirth
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Androgen Deprivation Therapy and Alzheimer's DiseaseMichael Froehner, Manfred P Wirth
Pageof 20

Showing results (21-30 of 191) with videos related to

Sort By:
Pageof 20
The Journal of Urology|May 20, 2015
Should the Urologist Treat Castration Resistant Prostate Cancer? YesManfred P Wirth, Michael Froehner
European Urology|July 4, 2012
Words of wisdom. Re: Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trialsMichael Froehner, Manfred P Wirth
European Urology|December 4, 2012
Re: Vincenzo Ficarra, Giacomo Novara, Raymond C. Rosen, et al. systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol 2012;62:405-17Michael Froehner, Manfred P Wirth
European Urology|January 29, 2010
Robot-assisted radical prostatectomy: the new gold standard?Manfred P Wirth, Michael Froehner
European Urology|October 6, 2014
Re: Firas Abdollah, Giorgio Gandaglia, Nazareno Suardi, et al. More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer. Eur Urol 2015;67:212-9: Extended Lymph Node Dissection and the Will Rogers PhenomenonMichael Froehner, Manfred P Wirth
The New England Journal of Medicine|October 30, 2014
Enzalutamide in metastatic prostate cancer before chemotherapyMichael Froehner, Manfred P Wirth
Lancet (London, England)|January 11, 2011
Cabazitaxel for castration-resistant prostate cancerMichael Froehner, Manfred P Wirth
Journal of Comparative Effectiveness Research|October 29, 2014
Approaches to radical prostatectomyMichael Froehner, Manfred P Wirth
Drugs & Aging|October 8, 2013
Locally advanced prostate cancer: optimal therapy in older patientsMichael Froehner, Manfred P Wirth
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Androgen Deprivation Therapy and Alzheimer's DiseaseMichael Froehner, Manfred P Wirth
Pageof 20